Largest Positive Opening Gaps for NVO

Novo Nordisk rises as FDA approves Wegovy pill for obesity (22-Dec-2025, 12:00 AM Seeking Alpha News)

Europe markets rebound, led by pharma gains (23-Dec-2025, 12:00 AM Seeking Alpha News)

European market rebound led by pharma gains (23-Dec-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Tuesday: ZIM, NVO, and more (23-Dec-2025, 12:00 AM Seeking Alpha News)

Novo’s Wegovy pill could be a game-changer, but Lilly is not far behind (23-Dec-2025, 12:00 AM Seeking Alpha News)

European market rebound led by pharma gains; STOXX 600 logs new record high (23-Dec-2025, 12:00 AM Seeking Alpha News)

Market Voices: Paramount-WBD, Trump vs. defense sector, Wegovy pill (23-Dec-2025, 12:00 AM Seeking Alpha News)

NOVO NORDISK A/S (NYSE: NVO) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by September 30, 2025 (17-Sep-2025, 8:12 AM PRNewswire)

Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (17-Sep-2025, 4:14 PM PRNewswire)

NVO DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important September 30 Deadline in Securities Class Action - NVO (17-Sep-2025, 5:00 PM Globe Newswire)

NVO Deadline: NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit (17-Sep-2025, 6:57 PM PRNewswire)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Lawsuit - NVO (18-Sep-2025, 8:45 AM PRNewswire)

NOVO NORDISK A/S (NYSE: NVO) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Novo Nordisk A/S Investors of Upcoming Deadline (18-Sep-2025, 9:38 AM Globe Newswire)

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO (18-Sep-2025, 10:00 AM PRNewswire)

DEADLINE ALERT for FLYW, LMT, SOC, NVO: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions (18-Sep-2025, 1:08 PM Globe Newswire)

Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact The Gross Law Firm (18-Sep-2025, 4:41 PM Globe Newswire)

Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO (18-Sep-2025, 5:58 PM PRNewswire)

Eli Lilly posts detailed results from ATTAIN-1 late-stage trial for obesity pill (17-Sep-2025, 12:00 AM Seeking Alpha News)

Lilly obesity pill more effective to Novo's oral semaglutide in diabetes trial (17-Sep-2025, 12:00 AM Seeking Alpha News)

FDA targets drug marketing, advertising with slew of warning letters (17-Sep-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk’s Wegovy pill delivers 16.6% weight loss in people with obesity (18-Sep-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk pops after Ozempic beats Lilly’s older drug in heart risk study (18-Sep-2025, 12:00 AM Seeking Alpha News)

4 stocks to watch on Thursday: PLTR, NVO, DRI, AMD (18-Sep-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Thursday: INTC, NVO, ETNB, REPL, and more (18-Sep-2025, 12:00 AM Seeking Alpha News)

Roche deal to buy 89bio boosts MASH space (18-Sep-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk reduces its U.S. sales team for obesity and diabetes education: Reuters (18-Sep-2025, 12:00 AM Seeking Alpha News)

September 30, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against NVO (15-Aug-2025, 9:15 AM PRNewswire)

Faruqi & Faruqi Reminds Novo Nordisk Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 30, 2025 - NVO (15-Aug-2025, 12:14 PM PRNewswire)

DEADLINE ALERT for FLYW, LMT, SOC, NVO: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions (15-Aug-2025, 1:13 PM Globe Newswire)

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit (15-Aug-2025, 4:45 PM PRNewswire)

Wegovy approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis (15-Aug-2025, 5:30 PM PRNewswire)

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO (16-Aug-2025, 10:00 AM PRNewswire)

Bragar Eagel & Squire, P.C. Reminds Investors of Novo, Altimmune, SelectQuote, and Spectrum that Lawsuits Have Been Filed and Encourages Investors to Contact the Firm (16-Aug-2025, 12:52 PM Globe Newswire)

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO (17-Aug-2025, 10:47 AM Globe Newswire)

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm (18-Aug-2025, 4:56 AM PRNewswire)

SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S (NYSE: NVO) (18-Aug-2025, 8:00 AM Globe Newswire)

Class Action Filed Against Novo Nordisk A/S (NVO) - September 30, 2025 Deadline to Join - Contact The Gross Law Firm (18-Aug-2025, 8:45 AM PRNewswire)

Novo Nordisk A/S (NVO) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (18-Aug-2025, 12:00 PM PRNewswire)

INVESTOR REMINDER: Berger Montague Notifies Novo Nordisk A/S (NYSE: NVO) Investors of a Class Action Lawsuit and Deadline (18-Aug-2025, 1:36 PM PRNewswire)

September 30, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against NVO (18-Aug-2025, 4:06 PM Globe Newswire)

Skye initiated at overweight at Evercore on obesity asset nimacimab (15-Aug-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk wins FDA label expansion for Wegovy against liver disease MASH (16-Aug-2025, 12:00 AM Seeking Alpha News)

Notable healthcare headlines for the week: UnitedHealth, Eli Lilly, Pfizer in focus (17-Aug-2025, 12:00 AM Seeking Alpha News)

European markets steady as traders eye Trump-Zelenskyy meeting; Novo Nordisk on the move (18-Aug-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Monday: NVO, DAY, and more (18-Aug-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk partners with GoodRx for $499 monthly Ozempic, Wegovy (18-Aug-2025, 12:00 AM Seeking Alpha News)

European markets steady as traders eye Trump-Zelenskyy meeting (18-Aug-2025, 12:00 AM Seeking Alpha News)

Eli Lilly, Novo Nordisk latest battle in GLP-1 market war: cash-paying customers (18-Aug-2025, 12:00 AM Seeking Alpha News)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO (6-Aug-2025, 10:00 AM PRNewswire)

Law Offices of Frank R. Cruz Encourages Novo Nordisk A/S (NVO) Investors To Inquire About Securities Fraud Class Action (6-Aug-2025, 12:07 PM Business Wire)

Law Offices of Howard G. Smith Encourages Novo Nordisk A/S (NVO) Investors To Inquire About Securities Fraud Class Action (6-Aug-2025, 1:15 PM Business Wire)

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Novo Nordisk A/S of Class Action Lawsuit and Upcoming Deadlines - NVO (6-Aug-2025, 6:40 PM PRNewswire)

Investors who lost money on Novo Nordisk A/S(NVO) should contact The Gross Law Firm about pending Class Action - NVO (7-Aug-2025, 8:45 AM PRNewswire)

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Novo Nordisk A/S (NVO) Investors To Inquire About Securities Fraud Class Action (7-Aug-2025, 2:53 PM Business Wire)

ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action - NVO (7-Aug-2025, 3:14 PM Globe Newswire)

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (7-Aug-2025, 4:00 PM PRNewswire)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 30, 2025 in Novo Lawsuit - NVO (7-Aug-2025, 4:36 PM Globe Newswire)

NOVO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Novo Nordisk A/S and Encourages Investors to Contact the Fir (7-Aug-2025, 7:16 PM Globe Newswire)

Novo Nordisk GAAP EPADR of DKK 12.49, revenue of DKK 154.94B; updates FY outlook (6-Aug-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk plans cost cuts amid slower Wegovy growth outlook (6-Aug-2025, 12:00 AM Seeking Alpha News)

Europe markets float in green as earnings dominate market sentiment (6-Aug-2025, 12:00 AM Seeking Alpha News)

5 stocks to watch on Wednesday: NVO, UBER, DIS, SHOP, MCD (6-Aug-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk boosts Prothena on plans for amyloidosis therapy (6-Aug-2025, 12:00 AM Seeking Alpha News)

Can Eli Lilly keep its GLP-1 crown? Q2 earnings will tell (6-Aug-2025, 12:00 AM Seeking Alpha News)

Europe markets mixed as earnings, tariff uncertainty dominate market sentiment (6-Aug-2025, 12:00 AM Seeking Alpha News)

Eli Lilly falls after late-stage trial data for oral weight loss therapy (7-Aug-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Thursday: ABNB, DKNG, LLY, and more (7-Aug-2025, 12:00 AM Seeking Alpha News)

Eli Lilly drops as trial data for oral weight loss drug weigh on Q2 results (7-Aug-2025, 12:00 AM Seeking Alpha News)

Eli Lilly drops as trial data for oral obesity drug weigh on Q2 results (7-Aug-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Thursday: ABNB, DKNG, LLY, PTON, DUO, and more (7-Aug-2025, 12:00 AM Seeking Alpha News)

SA Asks: How could higher India tariffs impact drug stocks? (7-Aug-2025, 12:00 AM Seeking Alpha News)

Should Eli Lilly slide on data for obesity pill despite Q2 beat? (7-Aug-2025, 12:00 AM Seeking Alpha News)

CVS Health to exit Obamacare; in pact with Novo to improve Wegovy access (1-May-2025, 12:00 AM Seeking Alpha News)

Eli Lilly slips after lowering earnings outlook (1-May-2025, 12:00 AM Seeking Alpha News)

CVS Health picks Novo’s Wegovy ahead of Lilly’s Zepbound (1-May-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Thursday: MSFT, META, CVS, and more (1-May-2025, 12:00 AM Seeking Alpha News)

WHO set to back use of weight loss drugs such as Zepbound, Wegovy - report (1-May-2025, 12:00 AM Seeking Alpha News)

Cigna to launch specialized GLP-1 pharmacy next month (2-May-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk says oral version of Wegovy accepted for FDA review (2-May-2025, 12:00 AM Seeking Alpha News)

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Novo Nordisk A/S(NVO) Shareholders (4-Mar-2025, 5:45 AM PRNewswire)

Lost Money on Novo Nordisk A/S(NVO)? Join Class Action Suit Seeking Recovery Contact Levi & Korsinsky (4-Mar-2025, 12:29 PM Globe Newswire)

Novo Nordisk introduces NovoCare Pharmacy, lowering cost of all doses of FDA-approved Wegovy (semaglutide) to $499 per month and offering easy home delivery for cash-paying patients (5-Mar-2025, 8:00 AM PRNewswire)

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk (5-Mar-2025, 10:22 AM PRNewswire)

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (5-Mar-2025, 4:00 PM Globe Newswire)

Novo Nordisk launches NovoCare rivaling Eli Lilly’s LillyDirect (5-Mar-2025, 12:00 AM Seeking Alpha News)

Amgen begins late-stage trials for obesity therapy (5-Mar-2025, 12:00 AM Seeking Alpha News)

Investors in Novo Nordisk A/S Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights - NVO (14-Feb-2025, 5:45 AM PRNewswire)

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action NVO (14-Feb-2025, 1:16 PM Globe Newswire)

NVO STOCK NEWS: NVO Shareholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Novo Nordisk A/S (14-Feb-2025, 5:51 PM Globe Newswire)

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit (16-Feb-2025, 4:00 PM Globe Newswire)

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit (17-Feb-2025, 4:32 PM PRNewswire)

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in Novo Lawsuit - NVO (18-Feb-2025, 5:45 AM PRNewswire)

NOVO NORDISK A/S (NYSE: NVO) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Novo Nordisk A/S Investors of Upcoming Deadline (18-Feb-2025, 7:15 AM Globe Newswire)

Levi & Korsinsky Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 NV (18-Feb-2025, 2:25 PM Globe Newswire)

INVESTOR ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Lawsuit Against Novo Nordisk A/S - NVO (18-Feb-2025, 6:21 PM PRNewswire)

Sanofi gets FDA approval for NovoLog insulin biosimilar (14-Feb-2025, 12:00 AM Seeking Alpha News)

What’s ahead for Eli Lilly and Novo as RFK Jr. takes over HHS (15-Feb-2025, 12:00 AM Seeking Alpha News)

Hims & Hers downgraded at Morgan Stanley on recent rally (18-Feb-2025, 12:00 AM Seeking Alpha News)

RFK Jr. tells HHS staffers childhood vaccines, psychiatric drugs on his radar (18-Feb-2025, 12:00 AM Seeking Alpha News)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Novo Nordisk A/S Securities and Sets a Lead Plaintiff Deadline of March 25, 2025 (24-Jan-2025, 3:52 PM Globe Newswire)

NVO INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead the Novo Nordisk Class Action Lawsuit (24-Jan-2025, 5:26 PM Globe Newswire)

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk (24-Jan-2025, 6:02 PM Globe Newswire)

Allurion stock soars 70% on weight-loss therapy update (23-Jan-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk spikes as novel obesity drug causes up to 22% of weight loss (24-Jan-2025, 12:00 AM Seeking Alpha News)

Biggest stock movers Friday: DAN, NVO, TXN, and more (24-Jan-2025, 12:00 AM Seeking Alpha News)

U.K. pharma group criticizes Novo over patient payments: report (24-Jan-2025, 12:00 AM Seeking Alpha News)

Novo Nordisk GAAP EPS of DKK 10.17, revenue of DKK 133.41B; updates FY24 outlook (7-Aug-2024, 12:00 AM Seeking Alpha News)

Novo Nordisk GAAP EPS of DKK 10.17, revenue of DKK 133.41B; raises FY24 outlook (7-Aug-2024, 12:00 AM Seeking Alpha News)

Novo Nordisk boosts sales outlook on soaring demand for weight-loss therapy (7-Aug-2024, 12:00 AM Seeking Alpha News)

Amgen cut at Wells Fargo; says obesity success is already priced in (7-Aug-2024, 12:00 AM Seeking Alpha News)

Abbott to integrate CGM system with Medtronic's insulin delivery devices (7-Aug-2024, 12:00 AM Seeking Alpha News)

Abbott to integrate CGM with Medtronic's insulin delivery devices (7-Aug-2024, 12:00 AM Seeking Alpha News)

4 stocks to watch on Wednesday: DIS, NVO and more (7-Aug-2024, 12:00 AM Seeking Alpha News)

Novo Nordisk stock falls as Wegovy Q2 sales miss the mark (7-Aug-2024, 12:00 AM Seeking Alpha News)

Eli Lilly jumps after guidance raise on weight loss momentum (8-Aug-2024, 12:00 AM Seeking Alpha News)

Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial (8-Aug-2023, 11:07 AM Globe Newswire)